Bacteriophage P100 for control of Listeria monocytogenes in foods:: Genome sequence, bioinformatic analyses, oral toxicity study, and application

被引:330
作者
Carlton, RM
Noordman, WH
Biswas, B
de Meester, ED
Loessner, MJ
机构
[1] EBI Food Safety BV, NL-2582 NE The Hague, Netherlands
[2] NIZO Food Res, NL-6710 Ede, Netherlands
[3] Exponential Biotherapies Inc, Washington, DC 20005 USA
[4] Swiss Fed Inst Technol, Inst Food Sci & Nutr, ETH, CH-8092 Zurich, Switzerland
关键词
bacteriophage; listeria monocytogenes; toxicity; genome sequence; food safety;
D O I
10.1016/j.yrtph.2005.08.005
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Listeria monocytogenes is an opportunistic foodborne pathogen responsible for Listeriosis, a frequently fatal infection. This investigation represents a comprehensive approach to characterize and evaluate the broad host range, strictly virulent phage P100, which can infect and kill a majority of Listeria monocytogenes strains. First, the complete nucleotide sequence (131,384 basepairs) of the genome of P100 was determined, predicted to encode 174 gene products and 18 tRNAs. Bioinformatic analyses revealed that none of the putative phage proteins has any homologies to genes or proteins of Listeria or any other bacteria which are known or suspected to be toxins, pathogenicity factors, antibiotic resistance determinants, or any known allergens. Next, a repeated dose oral toxicity study in rats was conducted, which did not produce any abnormal histological changes, morbidity or mortality. Therefore, no indications for any potential risk associated with using P100 as a food additive were found. As proof of concept, and to determine the parameters for application of P100 to foods sensitive to Listeria contamination, surface-ripened red-smear soft cheese was produced. Cheeses were contaminated with low concentrations of L. monocytogenes at the beginning of the ripening period, and P100 was applied to the surface during the rind washings. Depending on the time points, frequency and dose of phage applications, we were able to obtain a significant reduction (at least 3.5 logs) or a complete eradication of Listeria viable counts, respectively. We found no evidence for phage resistance in the Listeria isolates recovered from samples. Taken together, our results indicate that P100 can provide an effective and safe measure for the control of Listeria contamination in foods and production equipment. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:301 / 312
页数:12
相关论文
共 41 条
  • [1] Application of host-specific bacteriophages to the surface of chicken skin leads to a reduction in recovery of Campylobacter jejuni
    Atterbury, RJ
    Connerton, PL
    Dodd, CER
    Rees, CED
    Connerton, IF
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2003, 69 (10) : 6302 - 6306
  • [2] Identification of IgE-binding epitopes on gliadins for patients with food allergy to wheat
    Battais, F
    Mothes, T
    Moneret-Vautrin, DA
    Pineau, F
    Kanny, G
    Popineau, Y
    Bodinier, M
    Denery-Papini, S
    [J]. ALLERGY, 2005, 60 (06) : 815 - 821
  • [3] THE ACTIVITY IN THE CHICKEN ALIMENTARY-TRACT OF BACTERIOPHAGES LYTIC FOR SALMONELLA-TYPHIMURIUM
    BERCHIERI, A
    LOVELL, MA
    BARROW, PA
    [J]. RESEARCH IN MICROBIOLOGY, 1991, 142 (05) : 541 - 549
  • [4] Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium
    Biswas, B
    Adhya, S
    Washart, P
    Paul, B
    Trostel, AN
    Powell, B
    Carlton, R
    Merril, CR
    [J]. INFECTION AND IMMUNITY, 2002, 70 (01) : 204 - 210
  • [5] Boyd EF, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P223
  • [6] Metagenomic analyses of an uncultured viral community from human feces
    Breitbart, M
    Hewson, I
    Felts, B
    Mahaffy, JM
    Nulton, J
    Salamon, P
    Rohwer, F
    [J]. JOURNAL OF BACTERIOLOGY, 2003, 185 (20) : 6220 - 6223
  • [7] Human volunteers receiving Escherichia coli phage T4 orally:: a safety test of phage therapy
    Bruttin, A
    Brüssow, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) : 2874 - 2878
  • [8] Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice
    Cerveny, KE
    DePaola, A
    Duckworth, DH
    Gulig, PA
    [J]. INFECTION AND IMMUNITY, 2002, 70 (11) : 6251 - 6262
  • [9] Lactobacillus plantarum bacteriophage LP65:: a new member of the SPO1-like genus of the family Myoviridae
    Chibani-Chennoufi, S
    Dillmann, ML
    Marvin-Guy, L
    Rami-Shojaei, S
    Brüssow, H
    [J]. JOURNAL OF BACTERIOLOGY, 2004, 186 (21) : 7069 - 7083
  • [10] In vitro and in vivo bacteriolytic activities of Escherichia coli phages:: Implications for phage therapy
    Chibani-Chennoufi, S
    Sidoti, J
    Bruttin, A
    Kutter, E
    Sarker, S
    Brüssow, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) : 2558 - 2569